The management of hypertrophic cardiomyopathy

N Engl J Med. 1997 Mar 13;336(11):775-85. doi: 10.1056/NEJM199703133361107.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / etiology
  • Cardiac Pacing, Artificial
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / genetics
  • Cardiomyopathy, Hypertrophic / therapy*
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control
  • Humans
  • Risk Factors
  • Ventricular Outflow Obstruction / etiology
  • Ventricular Outflow Obstruction / surgery
  • Ventricular Outflow Obstruction / therapy
  • Verapamil / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Verapamil

Grants and funding